Acura settles Oxecta dispute with Ranbaxy

08-05-2014

Acura settles Oxecta dispute with Ranbaxy

Photo: Burlingham / Shutterstock.com

Acura Pharmaceuticals and Ranbaxy have agreed to settle their patent infringement litigation related to painkiller Aversion (oxycodone hydrochloride), once marketed by Pfizer under its registered trademark Oxecta.


Acura, Ranbaxy, Oxecta, Aversion, patent settlement

LSIPR